Reasons, Efficacy and Safety of Switching to Dolutegravir-Based Regimens Among Virologically Suppressed PLWH: A Retrospective Cohort Study of 96 Weeks.

Meiju DengNa ChenXiaojie LaoXiaolei WangJiantao FuLulu XingHongxin Zhao

Published in: Infection and drug resistance (2024)

This study confirmed the virologic efficacy of switching to DTG-based regimens in virologically suppressed PLWH over a 96-week period. The findings also expanded the evidence of immune reconstitution and metabolic safety associated with this switch.

Keyphrases

hiv infected patients
hiv infected
antiretroviral therapy
randomized controlled trial
clinical trial